Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 510.08
   
  • Change Today:
    $6.83
  • 52 Week High: $559.27
  • 52 Week Low: $407.37
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 1,480,861
  • Market Cap: $120,374m
  • RiskGrade: 164
  • Beta: 0.01

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 510.08
Change Today $ 6.83
% Change 1.36 %
52 Week High $559.27
52 Week Low $407.37
Volume 1,480,861
Shares Issued 235.99m
Market Cap $120,374m
Beta 0.01
RiskGrade 164

What The Brokers Say

Strong Buy 8
Buy 14
Neutral 5
Sell 0
Strong Sell 1
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 09-Oct-2026

Time Volume / Share Price
15:59 1,799 @ $510.07
15:59 56 @ $510.28
15:59 120 @ $510.26
15:59 45 @ $510.17
15:59 88 @ $509.97

Top of Page